Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.1020
-0.0100 (-8.93%)
At close: Oct 21, 2026, 4:00 PM EDT
0.0976
-0.0044 (-4.31%)
After-hours: Oct 21, 2026, 7:14 PM EDT
Cellyan Biotechnology Employees
Cellyan Biotechnology had 11 employees as of March 31, 2026. The number of employees decreased by 16 or 59.26% compared to the previous year. That makes Cellyan Biotechnology the 39,951st largest employer in the world and 5,974th in the United States.
Employees
11
Change (1Y)
-16
Growth (1Y)
-59.26%
Revenue / Employee
$1,221,228
Profits / Employee
-$103,269
Market Cap
2.40M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 11 | -16 | -59.26% |
| Mar 31, 2025 | 27 | 8 | 42.11% |
| Mar 31, 2024 | 19 | -17 | -47.22% |
| Mar 31, 2023 | 36 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cardinal Health | 63,900 |
| Cencora | 51,000 |
| McKesson | 43,000 |
| Henry Schein | 25,000 |
| Accendra Health | 6,500 |
| 111, Inc. | 1,063 |
| EDAP TMS | 289 |
| Cosmos Health | 163 |
HKPD News
- 11 hours ago - Cellyan Biotechnology to implement 1-for-20 reverse stock split - TheFly
- 12 hours ago - Cellyan Biotechnology Announces a 1-for-20 Reverse Stock Split - GlobeNewsWire
- 3 months ago - Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period - GlobeNewsWire
- 4 months ago - Cellyan Biotechnology files $200M mixed securities shelf - TheFly
- 6 months ago - Cellyan Biotechnology Co. files to sell 12.5M Class A ordinary shares for holder - TheFly
- 9 months ago - Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency - GlobeNewsWire
- 10 months ago - Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders - GlobeNewsWire
- 10 months ago - DCS Announces Q3 2025 Quarterly Financial Statements - Newsfile Corp